CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies ; volume:41 ; number:1 ; day:30 ; month:4 ; year:2022 ; pages:1-16 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (30.4.2022), 1-16, 12.2022
- Urheber
-
Bruno, Samantha
Ghelli Luserna di Rorà, Andrea
Napolitano, Roberta
Soverini, Simona
Martinelli, Giovanni
Simonetti, Giorgia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02363-9
- URN
-
urn:nbn:de:101:1-2022071011012966232447
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bruno, Samantha
- Ghelli Luserna di Rorà, Andrea
- Napolitano, Roberta
- Soverini, Simona
- Martinelli, Giovanni
- Simonetti, Giorgia
- SpringerLink (Online service)
Ähnliche Objekte (12)
BCL-2 as therapeutic target for hematological malignancies
Deubiquitinases in hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Deubiquitinases in hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Deubiquitinases in hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies